Development of protease inhibitors and the fight with drug-resistant HIV-1 variants.
Mitsuya
Hiroaki
H
The Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.
Maeda
Kenji
K
Das
Debananda
D
Ghosh
Arun K
AK
D023241:Antiretroviral Therapy, Highly Active; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology* / Q000235:genetics; D006801:Humans; D013329:Structure-Activity Relationship
D017320:HIV Protease Inhibitors